Related Experiment Video
Updated: Jul 19, 2026
08:23
Chronic Constriction of the Sciatic Nerve and Pain Hypersensitivity Testing in Rats
Published on: March 13, 2012
Acrylamide alters cytoskeletal protein level in rat sciatic nerves
Sufang Yu1, Fuyong Son, Jinxia Yu
1Institute of toxicology, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, P.R. China.
Neurochemical Research
|October 18, 2006
Summary
Acrylamide (ACR) exposure causes peripheral neuropathy by altering nerve cytoskeletal proteins. This study found ACR significantly changed neurofilament and tubulin levels in rat sciatic nerves, suggesting a molecular mechanism for nerve damage.
Area of Science:
- Neuroscience
- Toxicology
- Molecular Biology
Background:
- Occupational exposure to acrylamide (ACR) is known to cause peripheral neuropathy.
- Nerve degeneration is a key characteristic of ACR-induced neuropathy.
Purpose of the Study:
- To investigate the molecular mechanisms underlying acrylamide-induced peripheral neuropathy.
- To analyze the impact of ACR on cytoskeletal protein levels in rat sciatic nerves.
Main Methods:
- Adult Wistar rats were administered ACR (20, 40 mg/kg) intraperitoneally three times weekly for eight weeks.
- Sciatic nerves were fractionated into pellet and supernatant components after Triton extraction.
- Levels of neurofilament subunits (NF-L, NF-M, NF-H), alpha-tubulin, beta-tubulin, and beta-actin were quantified using SDS-PAGE and immunoblotting.
Main Results:
- High-dose ACR significantly decreased neurofilament subunits (NF-L, NF-M, NF-H) in both sciatic nerve fractions, with an exception for NF-M in the pellet.
- Alpha-tubulin and beta-tubulin levels increased in the supernatant but decreased in the pellet fraction.
- Beta-actin levels increased significantly in the supernatant but showed no significant change in the pellet.
Conclusions:
- Acrylamide exposure alters the levels of key cytoskeletal proteins in the sciatic nerve.
- These alterations in cytoskeletal protein composition are a potential molecular mechanism contributing to acrylamide-induced peripheral neuropathy.
